Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold
David Power(Cardiovascular Institute of the South), Gregg W. Stone(Cardiovascular Institute of the South), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Ziad A. Ali(St. Francis Hospital), Stephen G. Ellis(Université de Perpignan), Runlin Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Anton Camaj(Columbia University Irving Medical Center), Dean J. Kereiakes(Health Net), Takeshi Kimura(Municipal Hirakata City Hospital), Kelly A. Stockelman(Abbott (United States)), Patrick W. Serruys(St. Luke's Hospital), Ovidiu Dressler(Cardiovascular Research Foundation)
Cited by 19
Related Papers
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2011|2.2k